Esophagus Cancer Completed Phase 3 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00193882Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.Treatment